Although PTEN and FKBP51 regulated PD-L1 expression in gliomas [29, 43], the complicated regulatory mechanisms of PD-L1 expression need to be further investigated to accurately select patients and reduce resistance to PD-1 treatment in “cold” gliomas. The gene discussed is PTEN; the disease is central nervous system cancer.